Liu Xiao-Yu, Zhang Bin, Cheng Yu-Xi, Tao Wei, Yuan Chao, Wei Zheng-Qiang, Peng Dong
Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
World J Gastrointest Oncol. 2022 Jun 15;14(6):1199-1209. doi: 10.4251/wjgo.v14.i6.1199.
The effect of chronic kidney disease (CKD) on the outcomes of colorectal cancer (CRC) patients after primary CRC surgery is controversial.
To analyze whether CKD had specific effect on the outcomes after CRC surgery.
We searched the PubMed, Embase, Cochrane Library databases and CNKI, from inception to March 14, 2022. Newcastle-Ottawa Scale was used for the quality assessment in this meta-analysis, and we used RevMan 5.3 was used for data analysis.
A total of nine studies including 47771 patients were eligible for this meta-analysis. No significant difference was found in terms of overall postoperative complications [odds ratio (OR) = 1.78, 95%CI: 0.64-4.94, = 0.27]. We analyzed the specific complications and found that the CKD group had higher rates of pulmonary infection (OR = 2.70, 95%CI: 1.82-4.00, < 0.01), cardiovascular complications (OR = 3.39, 95%CI: 2.34-4.91, < 0.01) and short-term death (OR = 3.01, 95%CI: 2.20-4.11, < 0.01). After pooling the hazard ratio (HR), the CKD group had worse overall survival (OS) (HR = 1.51, 95%CI: 1.04-2.20, = 0.03). We performed subgroup analyses of the dialysis and non-dialysis groups, and no significant difference was found in the non-dialysis group (HR = 1.20, 95%CI: 0.98-1.47, = 0.08). The dialysis group had worse OS (HR = 3.36, 95%CI: 1.92-5.50, < 0.01) than the non-dialysis group. The CKD group had worse disease-free survival (DFS) (HR = 1.41, 95%CI: 1.12-1.78, < 0.01), and in the subgroup analysis of the dialysis and non-dialysis groups, no significant difference was found in the non-dialysis group (HR = 1.27, 95%CI: 0.97-1.66, = 0.08). The dialysis group had worse OS (HR = 1.95, 95%CI: 1.23-3.10, < 0.01) than the non-dialysis group.
Preexisting CKD was associated with higher rates of pulmonary infection, higher rates of short-term death, and worse OS and poorer DFS following CRC surgery.
慢性肾脏病(CKD)对原发性结直肠癌(CRC)手术后患者预后的影响存在争议。
分析CKD对CRC手术后的预后是否有特定影响。
检索了PubMed、Embase、Cochrane图书馆数据库以及中国知网,检索时间从建库至2022年3月14日。本荟萃分析采用纽卡斯尔-渥太华量表进行质量评估,并使用RevMan 5.3进行数据分析。
共有9项研究、47771例患者符合本荟萃分析的纳入标准。术后总体并发症方面未发现显著差异[比值比(OR)=1.78,95%置信区间(CI):0.64 - 4.94,P = 0.27]。我们分析了特定并发症,发现CKD组肺部感染发生率更高(OR = 2.70,95%CI:1.82 - 4.00,P < 0.01)、心血管并发症发生率更高(OR = 3.39,95%CI:2.34 - 4.91,P < 0.01)以及短期死亡率更高(OR = 3.01,95%CI:2.20 - 4.11,P < 0.01)。汇总风险比(HR)后,CKD组的总生存期(OS)更差(HR = 1.51,95%CI:1.04 - 2.20,P = 0.03)。我们对透析组和非透析组进行了亚组分析,非透析组未发现显著差异(HR = 1.20,95%CI:0.98 - 1.47,P = 0.08)。透析组的OS比非透析组更差(HR = 3.36,95%CI:1.92 - 5.50,P < 0.01)。CKD组的无病生存期(DFS)更差(HR = 1.41,95%CI:1.12 - 1.78,P < 0.01),在透析组和非透析组的亚组分析中,非透析组未发现显著差异(HR = 1.27,95%CI:0.97 - 1.66,P = 0.08)。透析组的OS比非透析组更差(HR = 1.95,95%CI:1.23 - 3.10,P < 0.01)。
术前存在CKD与CRC手术后肺部感染发生率升高、短期死亡率升高以及OS更差和DFS更差相关。